| 曲美他嗪在心血管疾病中的临床应用进展 |
| |
| 引用本文： | 夏铭蔚,马礼坤.曲美他嗪在心血管疾病中的临床应用进展[J].医学综述,2008,14(14):2186-2188. |
| |
| 作者姓名： | 夏铭蔚 马礼坤 |
| |
| 作者单位： | 安徽医科大学附属省立医院心内科,合肥,230001 |
| |
| 摘 要： | 曲美他嗪作为一种新型的抗心绞痛药物,通过抑制脂肪酸氧化、增加葡萄糖的利用,从而改善心肌细胞的能量代谢,具有保护心肌作用,且不影响血流动力学,临床应用日益广泛。本文就曲美他嗪在心血管疾病中的临床应用予以综述。
|
| 关 键 词： | 曲美他嗪 能量代谢 心血管疾病 |
Progress of Trimetazidine in Treatment of Cardiovascular Diseases |
| |
| XIA Ming-wei,MA Li-kun.Progress of Trimetazidine in Treatment of Cardiovascular Diseases[J].Medical Recapitulate,2008,14(14):2186-2188. |
| |
| Authors: | XIA Ming-wei MA Li-kun |
| |
| Institution: | XIA Ming-wei,MA Li-kun.(Department of Cardiology,the Affiliated Provincial Hospital of Anhui Medical University,Hefei 230001,China) |
| |
| Abstract: | As a new type of anti-ischaemic drug,trimetazidine has good protection effects on human myocardium through inhibiting fatty acid oxidation,increasing glucose metabolism and improving energy metabolism in myocardial cells.Trimetazidine has been widely used in clinical experiences without effects on hemodynamics.This article reviewed the clinical application of trimetazidine in treatment of cardiovascular diseases. |
| |
| Keywords: | Trimetazidine Energy metabolism Cardiovascular diseases |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
